Alzheimer’s patients who take Leqembi retain the benefits of the treatment even when they stop taking it, new research by Eisai and Biogen shows.
People of color on dialysis have a higher risk of staph bloodstream infections than white people, according to the CDC.
){kind=link}
){kind=link}